NACDS and our in-state partners, the California Pharmacists Association and the California Retailers Association, are supporting AB 1710 by Assembly Member Wood, legislation that will leverage pharmacists to administer the COVID-19 vaccine as soon as it is viable.

Also in California. The Board of Pharmacy will be meeting virtually on July 29 and 30, 2020. The agenda and meeting materials are available here.

Also in California. Several temporary pharmacy waivers are set to expire.  Below is a list of those waivers that have expired or will be expiring in July.

Also in California. The Board of Pharmacy extended three previously approved waivers through September 22, 2020.

Also in California. The Board of Pharmacy has published a final rule that amends regulations under 16 CCR 1707 to revise the duty to consult standards for pharmacists. The rule specifies the minimum time requirements a pharmacist must be available to speak to patients, and the maximum amount of time a consumer must wait before speaking to a pharmacist. The rule also expands the current requirements for when a pharmacist must provide oral consultation to all settings, effective October 1, 2020.

Also in California. The Department of Managed Health Care released a notice to announce its  All Plan Letter 20-024 to health care service plans in Riverside and Sonoma counties. The notice provides guidance on reporting requirements under a pilot project to assess the impact of health care service plans and pharmacy benefit manager prohibitions on the dispensing of certain amounts of prescription drugs by network retail pharmacies. All reporting will be required annually by July 1. The pilot project will be in effect until Jan. 1, 2023.

For more information, contact NACDS’ Mary Staples at 817-442-1155.